A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
For years, traditional cable had one trump card against the upstart streamers devouring their business: live programming. Not anymore.
TD Bank was fined more than $3 billion by regulators in October in what’s arguably the biggest banking scandal of the year.
Europe’s bank M&A scene has been noticeably stagnant for a while, but that could all be about to change next year.